Shanxi Peisen Biotechnology

Shanxi Peisen Biotechnology is a Chinese biotechnology company specializing in the research, development, and industrial-scale production of recombinant humanized collagen (rhCollagen). Utilizing advanced synthetic biology techniques, the company produces high-purity Type III collagen that is bio-identical to human sequences, ensuring high biocompatibility and eliminating the risks associated with animal-derived proteins. Their product portfolio includes medical-grade raw materials and finished medical devices such as collagen dressings, gels, and lyophilized powders. Peisen operates state-of-the-art GMP-compliant manufacturing facilities designed for high-efficiency fermentation and purification. The company's innovations primarily target the medical aesthetics, regenerative medicine, and functional skincare markets. By focusing on the mass production of bioactive proteins, Peisen aims to provide standardized solutions for clinical wound repair and anti-aging applications.